Literature DB >> 4934014

Hereditary disorders of blood coagulation due to defective and deficient synthesis of protein.

D P Jackson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4934014      PMCID： PMC2441040     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  27 in total

Review 1.  Genetic disorders of blood coagulation.

Authors:  C R Prentice; O D Ratnoff
Journal:  Semin Hematol       Date:  1967-04       Impact factor: 3.851

2.  A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore').

Authors:  E A Beck; P Charache; D P Jackson
Journal:  Nature       Date:  1965-10-09       Impact factor: 49.962

3.  An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland.

Authors:  W B Forman; O D Ratnoff; M H Boyer
Journal:  J Lab Clin Med       Date:  1968-09

4.  Congenital disorders of fibrinogen.

Authors:  D P Jackson; E A Beck; P Charache
Journal:  Fed Proc       Date:  1965 Jul-Aug

5.  Inherited fibrinogen abnormality causing thrombophilia.

Authors:  O Egeberg
Journal:  Thromb Diath Haemorrh       Date:  1967-02-28

6.  Familial disturbance of fibrin monomer aggregation.

Authors:  A Von Felten; F Duckert; P G Frick
Journal:  Br J Haematol       Date:  1966-11       Impact factor: 6.998

7.  [Hemorrhagic diathesis with dominant heredity, caused by an abnormal fibrinogen (fibrinogen Baltimore)].

Authors:  E A Beck; M W Mosesson; P Charache; D P Jackson
Journal:  Schweiz Med Wochenschr       Date:  1966-09-17

8.  [Immunologic study of human prothrombin and thrombin].

Authors:  F Josso; J M Lavergne; C Weilland; J P Soulier
Journal:  Thromb Diath Haemorrh       Date:  1967-12-31

9.  Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?

Authors:  M Blombäck; B Blombäck; E F Mammen; A S Prasad
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

10.  Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.

Authors:  H R Roberts; J E Grizzle; W D McLester; G D Penick
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808
View more
  5 in total

1.  Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq.

Authors:  Daesik Kim; Beum-Chang Kang; Jin-Soo Kim
Journal:  Nat Protoc       Date:  2021-01-18       Impact factor: 13.491

2.  Molecular deficiencies of human blood coagulation.

Authors:  E A Beck
Journal:  Experientia       Date:  1972-01-15

Review 3.  Design and analysis of CRISPR-Cas experiments.

Authors:  Ruth E Hanna; John G Doench
Journal:  Nat Biotechnol       Date:  2020-04-13       Impact factor: 54.908

4.  Characterization of Mammalian In Vivo Enhancers Using Mouse Transgenesis and CRISPR Genome Editing.

Authors:  Marco Osterwalder; Stella Tran; Riana D Hunter; Eman M Meky; Kianna von Maydell; Anne N Harrington; Janeth Godoy; Catherine S Novak; Ingrid Plajzer-Frick; Yiwen Zhu; Jennifer A Akiyama; Veena Afzal; Evgeny Z Kvon; Len A Pennacchio; Diane E Dickel; Axel Visel
Journal:  Methods Mol Biol       Date:  2022

5.  poly(UG)-tailed RNAs in genome protection and epigenetic inheritance.

Authors:  Aditi Shukla; Jenny Yan; Daniel J Pagano; Anne E Dodson; Yuhan Fei; Josh Gorham; J G Seidman; Marvin Wickens; Scott Kennedy
Journal:  Nature       Date:  2020-05-20       Impact factor: 49.962
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.